Herbalife Ltd. (NYSE: HLF) announced that global sports icon Cristiano Ronaldo has acquired a 10% equity stake in HBL Pro2col Software, LLC, the subsidiary that holds Herbalife’s Pro2col technology as part of a broader strategic partnership aimed at scaling personalized digital wellness worldwide.
This transaction marks a deepening of Ronaldo’s long-standing relationship with Herbalife, shifting him from ambassador and partner into an active investor and strategic collaborator in the company’s technology ecosystem.
Pro2col is described by Herbalife as a digital wellness operating system that combines:
The technology integrates digital capabilities with Herbalife’s existing product and distributor community to promote individualized wellness experiences.
position itself beyond traditional nutrition products by integrating data analytics, technology, and community-driven engagement into its long-term growth strategy.
The Pro2col platform is currently in phased beta rollout in the U.S., Canada, and Puerto Rico, with plans to expand to select markets in Europe, the Middle East, and Africa later in 2026.
Ronaldo has been associated with Herbalife since 2013, initially as a brand ambassador in its global nutrition partnership. His extended role as investor signals confidence in the future of personalized wellness technology and reflects a commitment to expand the reach of data-driven nutrition solutions.
In statements referenced by Herbalife, Ronaldo emphasized that the investment was a natural evolution of his long-term relationship with the company and its community, reinforcing his belief in the ability of technology to help individuals manage their health more effectively.
Herbalife describes Pro2col as a core element of its strategy to become a more connected, digitally enabled health and wellness platform, integrating products, technology, and community support. The company’s independent distributors are expected to benefit from enhanced tools and insights designed to drive greater engagement and personalized customer experiences.
For investors and industry watchers, Ronaldo’s equity stake:
While Pro2col is still in early commercial rollout, the involvement of a globally recognized figure like Ronaldo is likely to generate additional visibility and credibility for the initiative.
Get more information
There are no reviews yet. Be the first one to write one.
